In addition, high TGF-β1 levels correlate with tumor vascularity, metastasis and poor survival in HCC making TGF-β pathway a promising target in HCC therapy (Ito et al., 1995; Okumoto et al., 2004). This evidence concerns the gene TGFB1 and neoplasm.